Caregen Co. Ltd

Caregen, a global leader in peptide research and development, is a global biotechnology company that has commercialized the unlimited expandability of its patented peptides as many innovative products since its establishment in 2001. Over 600 different functional peptides developed by Caregen for the past 19 years have opened new paradigm in the field of biotechnology by expanding its applications to cosmeceutical, Class III medical devices, food supplement, and pharmaceuticals. We are striving to dramatically improve human life and health providing total health care solution through the development, production, and supply of various peptides. Our innovative peptide-based products provide solutions to many people around the world who are pursuing health and beauty with our unique skin delivery technology that maximize the efficacy and effectiveness of products Global leader in Peptide Research and development: Peptide-based products developed by Caregen provide total health care solutions across all areas of the anti-aging industry. By combining unique skin delivery technology, Caregen provides a variety of safe and highly effective cosmeceuticals and medical device products to 130 countries around the world. Caregen’s research goes beyond biomimetic peptide research and maximize the efficacy of biomimetic peptides with a new approach to hybrid peptides. We are expanding these hybrid peptides into a pharmaceutical product with optimal efficacy and safety Innovative R&D: One of the most important features that can define Caregen’s product development capabilities is a product with a variety of functions that are safe and effective for maximum use all based on our various patented peptides. In particular, PTx, which has the world’s first Botulinum Toxin Type C mechanism, provides innovative solutions to many people around the world as its application extending to management of hyperhidrosis, pain, and skin diseases by topical use.